BECRENZI
DEAD

Serial Number

79318534

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jun 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BECRENZI Trademark

Serial Number: 79318534 • Registration: 6624520

BECRENZI is a trademark filed by NOVARTIS AG on June 4, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 4, 2021

Registration Date

January 25, 2022

Published for Opposition

November 9, 2021

Cancellation Date

February 6, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 21, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Feb 21, 2025 DETH
NOTIFICATION PROCESSED BY IB
Jun 5, 2022 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
May 19, 2022 FICS
FINAL DISPOSITION PROCESSED
May 18, 2022 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 24, 2022 GPAR
TEAS SECTION 7 REQUEST RECEIVED
Jan 27, 2022 ES7R
POST PUBLICATION AMENDMENT – NOT ENTERED
Jan 25, 2022 CHPN
REGISTERED-PRINCIPAL REGISTER
Jan 25, 2022 R.PR
ASSIGNED TO PETITION STAFF
Jan 7, 2022 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Dec 20, 2021 EPPA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 16, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 16, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 16, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 16, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 16, 2021 COAR
PUBLISHED FOR OPPOSITION
Nov 9, 2021 PUBO
NOTICE OF PUBLICATION
Oct 20, 2021 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2021 CNSA
ASSIGNED TO EXAMINER
Sep 29, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 7, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 30, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 26, 2021 REPR